TB Alliance

Dr. Mel Spigelman Named R&D Director of Global Alliance for TB Drug Development

June 2, 2003

Veteran of Academia and Industry brings 20-plus years of expertise to International Public-Private Partnership The TB Alliance has announced the

June 2, 2003

Commitment to New Drugs for the Developing World for the Treatment of Infectious Diseases On June 2nd, AstraZeneca opened a

May 22, 2003

The Global Alliance for TB Drug Development (TB Alliance) welcomes the creation of a new research effort, the Foundation for

May 16, 2003

On May 16, the United States Senate voted to enact the “US Leadership Against AIDS, TB and Malaria” Bill. The

April 30, 2003

(Markel, H., and Doyle S.: The Epidemic Scorecard. The New York Times (Op-Ed Essay), April 30, 2003, p. A31.)

April 25, 2003

ScienceScope A South Korean research institute has been selected to help produce a faster cure for tuberculosis (TB). The nonprofit

April 25, 2003

The TB Alliance reached another important milestone in the portfolio building process on April 22. We announced the launch of

March 24, 2003

New Tuberculosis Drugs Required o Eliminate Epidemic, Meet Economic Development Goals Health Experts Urge Public & Industry Commitments New York,

March 24, 2003

Over the last few months, the TB Alliance advanced plans to enlist the R&D capacity of endemic countries. By consulting

March 1, 2003